Search

Loksidh D Ganorkar

from Pittsboro, NC
Age ~61
Get Report
Also known as:
Loksidh Devi Ganorkar, Loksidh D Ramkissoon, Devi Ramkissoon Loksidh, Ganorkar D Loksidh, Ramkissoon L Devi, A N
Related to:
Ganorkar M Ramkissoon, 61
Connected to:
Anais E Ganouna, 39Doreen R Ganoung, 80Judy L Ganoung, 67Lori R Ganoung, 64Kelly M Ganousis, 35Louis G Ganousis, 70Ashley Ganovsky, 35Jeffrey D Ganow, 41Arturo M Ganoza, 50Cynthia A Ganoza, 73

Loksidh Ganorkar Phones & Addresses

  • Pittsboro, NC
  • 5307 Willowbend Trl, Kalamazoo, MI 49009 (269) 353-6378
  • Apex, NC
  • 25 Jillian Blvd, Parsippany, NJ 07054 (973) 884-0609
  • 4 Broadview Rd, Millington, NJ 07946 (908) 647-3638
  • Morgan, NJ
  • 4 Broadview Rd, Millington, NJ 07946 (269) 353-6378

Work

Company: Cti clinical trial and consulting services Sep 2018 Position: Senior director regulatory and scientific affairs

Education

Degree: Doctorates, Doctor of Philosophy School / High School: University of Utah 1994 to 1998 Specialities: Chemistry

Skills

Pharmaceutical Industry • Drug Development • Clinical Development • Gmp • Technology Transfer

Industries

Pharmaceuticals

Resumes

Resumes

Loksidh Ganorkar Photo 1

Senior Director Regulatory And Scientific Affairs

View page
Location:
127 Deer Run, Pittsboro, NC 27312
Industry:
Pharmaceuticals
Work:
Cti Clinical Trial and Consulting Services
Senior Director Regulatory and Scientific Affairs
Novartis
Head of Regulatory Affairs Cmc - Fcc
Merck
Associate Director
Schering-Plough Research Institute
Associate Director
Pfizer 2002 - 2005
Principal Scientist
Education:
University of Utah 1994 - 1998
Doctorates, Doctor of Philosophy, Chemistry
Skills:
Pharmaceutical Industry
Drug Development
Clinical Development
Gmp
Technology Transfer

Business Records

Name / Title
Company / Classification
Phones & Addresses
Loksidh Ganorkar
Principal
Advanced Chemical Technologies
Mfg Chemical Preparations
5307 Willowbend Trl, Kalamazoo, MI 49009

Publications

Us Patents

Multiple Pulse Extended Release Formulations Of Clindamycin

View page
US Patent:
20030129236, Jul 10, 2003
Filed:
Dec 19, 2002
Appl. No.:
10/324718
Inventors:
John Heimlich - Portage MI, US
Robert Noack - Grand Rapids MI, US
Steven Cox - Schoolcraft MI, US
Loksidh Ganorkar - Kalamazoo MI, US
Ronald VerHage - Lawton MI, US
Ernest Lee - Kalamazoo MI, US
International Classification:
A61K031/704
A61K009/22
A61K009/26
US Classification:
424/470000, 514/035000
Abstract:
The present invention is directed to an oral dosage form for multiple-pulsed delivery of at least two fractions of clindamycin to a subject, one in an immediate-release form and the other in an extended release form. The oral dosage forms of the present invention provide a means for treating or preventing gram-positive bacterial infections with a minimal number of treatments per day, potentially, as little as once or twice per day.

Zero-Order Sustained Release Dosage Forms And Method Of Making Same

View page
US Patent:
20030133982, Jul 17, 2003
Filed:
Dec 19, 2002
Appl. No.:
10/324719
Inventors:
John Heimlich - Portage MI, US
Loksidh Ganorkar - Kalamazoo MI, US
Ernest Lee - Kalamazoo MI, US
Robert Noack - Grand Rapids MI, US
Ronald VerHage - Lawton MI, US
International Classification:
A61K009/26
A61K009/14
A61K031/445
US Classification:
424/469000, 514/317000, 514/049000, 514/152000, 514/262100, 514/192000, 514/561000, 514/252160, 514/253080, 424/679000, 514/211070
Abstract:
The present invention relates to zero-order sustained release solid dosage forms suitable for administration of a wide range of therapeutically active medicaments, especially those that are water-soluble, and to a process of making same. The solid dosage form comprises (a) a matrix core comprising ethylcellulose and the active agent and (b) a hydrophobic polymer coating encasing the entire matrix core.

Sustained-Release Tablet Composition Comprising A Dopamine Receptor Agonist

View page
US Patent:
20050079217, Apr 14, 2005
Filed:
Jul 24, 2003
Appl. No.:
10/626274
Inventors:
Loksidh Ganorkar - Kalamazoo MI, US
Joseph Reo - Kalamazoo MI, US
Alice Martino - Kalamazoo MI, US
Gregory Amidon - Portage MI, US
Connie Skoug - Portage MI, US
International Classification:
A61K009/20
US Classification:
424465000
Abstract:
A sustained-release pharmaceutical composition in a form of an orally deliverable tablet comprises as active pharmaceutical agent a compound of formula or a pharmaceutically acceptable salt thereof, wherein R, Rand Rare the same or different and are H, Calkyl (optionally phenyl substituted), Calkenyl or alkynyl or Ccycloalkyl, or where Ris as above and Rand Rare cyclized with the attached N atom to form pyrrolidinyl, piperidinyl, morpholinyl, 4-methylpiperazinyl or imidazolyl groups; X is H, F, Cl, Br, I, OH, Calkyl or alkoxy, CN, carboxamide, carboxyl or (Calkyl)carbonyl; A is CH, CH, CHF, CHCl, CHBr, CHI, CHCH, C═O, C═S, CSCH, C═NH, CNH, CNHCH, CNHCOOCH, CNHCN, SOor N; B is CH, CH, CHF, CHCl, CHBr, CHI, C═O, N, NH or NCH, and n is 0 or 1; and D is CH, CH, CHF, CHCl, CHBr, CHI, C═O, O, N, NH or NCH. The agent is dispersed in a matrix comprising a hydrophilic polymer and a starch having a tensile strength of at least about 0.15 kN cmat a solid fraction representative of the tablet. The composition exhibits sustained-release properties effective for treatment of Parkinson's disease. The tablet is optionally coated. Tablets of the invention have improved resistance to attrition or erosion during manufacture, packaging and handling.

Sustained-Release Tablet Composition Of Pramipexole

View page
US Patent:
20050226926, Oct 13, 2005
Filed:
Jul 23, 2003
Appl. No.:
10/626166
Inventors:
Gregory Amidon - Portage MI, US
Loksidh Ganorkar - Kalamazoo MI, US
John Heimlich - Portage MI, US
Ernest Lee - Kalamazoo MI, US
Robert Noack - Ann Arbor MI, US
Joseph Reo - Kalamazoo MI, US
Connie Skoug - Portage MI, US
International Classification:
A61K009/22
US Classification:
424468000
Abstract:
A sustained-release pharmaceutical composition in a form of an orally deliverable tablet comprises a water-soluble salt of pramipexole, dispersed in a matrix comprising a hydrophilic polymer and a starch having a tensile strength of at least about 0.15 kN cmat a solid fraction representative of the tablet.

Sustained-Release Tablet Composition

View page
US Patent:
20070196481, Aug 23, 2007
Filed:
Jul 24, 2003
Appl. No.:
10/626379
Inventors:
Gregory Amidon - Portage MI, US
Loksidh Ganorkar - Kalamazoo MI, US
John Heimlich - Portage MI, US
Ernest Lee - Kalamazoo MI, US
Alice Martino - Kalamazoo MI, US
Robert Noack - Grand Rapids MI, US
Joseph Reo - Kalamazoo MI, US
Connie Skoug - Portage MI, US
International Classification:
A61K 9/22
US Classification:
424468000, 073078000
Abstract:
A sustained-release pharmaceutical composition in a form of an orally deliverable tablet comprises an active pharmaceutical agent having solubility not less than about 10 mg/ml, dispersed in a matrix comprising a hydrophilic polymer and a starch having a tensile strength of at least about 0.15 kN cmat a solid fraction representative of the tablet.

Sustained-Release Tablet Composition

View page
US Patent:
20090143387, Jun 4, 2009
Filed:
Dec 19, 2008
Appl. No.:
12/339212
Inventors:
Gregory E. Amidon - Portage MI, US
Loksidh D. Ganorkar - Kalamazoo MI, US
John M. Heimlich - Portage MI, US
Ernest J. Lee - Kalamazoo MI, US
Alice C. Martino - Kalamazoo MI, US
Robert M. Noack - Grand Rapids MI, US
Joseph P. Reo - Kalamazoo MI, US
Connie J. Skoug - Portage MI, US
International Classification:
A61K 31/535
A61P 25/24
US Classification:
5142392
Abstract:
A sustained-release pharmaceutical composition in a form of an orally deliverable tablet containing reboxetine, or a pharmaceutically acceptable salt thereof, dispersed in a matrix containing a hydrophilic polymer and a starch, wherein the starch has a tensile strength of at least 0.15 kN cmat a solid fraction of 0.75 to 0.85.

Sustained-Release Tablet Composition Of Pramipexole

View page
US Patent:
20100316710, Dec 16, 2010
Filed:
Mar 3, 2010
Appl. No.:
12/716755
Inventors:
Gregory Everett AMIDON - Portage MI, US
Loksidh Devi GANORKAR - Kalamazoo MI, US
John Mark HEIMLICH - Portage MI, US
Ernest J. LEE - Kalamazoo MI, US
Robert Martin NOACK - Ann Arbor MI, US
Joseph Peter REO - Kalamazoo MI, US
Connie Jo SKOUG - Portage MI, US
Assignee:
BOEHRINGER INGELHEIM INTERNATIONAL GMBH - Ingelheim am Rhein
International Classification:
A61K 9/26
A61K 31/4184
A61P 25/16
US Classification:
424469, 514395
Abstract:
A sustained-release pharmaceutical composition in a form of an orally deliverable tablet comprises a water-soluble salt of pramipexole, dispersed in a matrix comprising a hydrophilic polymer and a starch having a tensile strength of at least about 0.15 kN cmat a solid fraction representative of the tablet.
Control profile
Loksidh D Ganorkar from Pittsboro, NC, age ~61 Get Report